Innovation Pharmaceuticals in Discussions to Advance Brilacidin into Human Trials Against COVID-19

by NASDAQ Market News April 6, 2020

NASDAQ Market News
Click here to email author

IMMUNOMEDICS ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AND THE APPOINTMENT OF HAROUT SEMERJIAN AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

Myriad Receives Reimbursement for the BRACAnalysis® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOC

Ads